Aphria Gets a 58% Price Target Bump From a Prominent Analyst
Aphria (NASDAQ: APHA) has become a favored marijuana stock lately, due to better-than-expected quarterly results and the looming merger with peer Tilray (NASDAQ: TLRY). The prognosticator believes that those second-quarter results "underscore Aphria's position of strength," despite a decline in sales for the company's key Canadian recreational marijuana segment. Stifel is maintaining its hold rating on the stock because subsequent price appreciation (based also on the prospects for the U.S. decriminalizing marijuana at the Federal level) limits the stock's potential to outperform.
